Interesting petition from the t315i community. This will certainly help Omapro with FDA approval but I still think the market is too small. One minor risk is that the FDA allows the drug to patients via special access scheme. This will make it more difficult to get US reimbursment.
http://www.petitiononline.com/FDAOMACE/petition.html